Increasing Prevalence of Acquired Hemophilia Among New Borns Demands Effective Treatment - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Acquired Hemophilia Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029" report has been added to ResearchAndMarkets.com's offering.

The Acquired Hemophilia Treatment Market is anticipated to grow at a compound annual growth rate of 3.3% for the forecast period of 2021 to 2029. This growth is mainly fueled by rising rate of prophylaxis treatment among patients. This report covers all the quantitative and qualitative aspects of the Acquired Hemophilia Market and also talks about its key drivers, the challenges it faces, the growth opportunities present in the market, and its future prospects.

Increasing Prevalence of AH among New Born Demands Effective Treatment

The key compelling factors of this market are increasing prevalence of Acquired Hemophilia in newborn, rising diagnostic rates, increasing use of Prophylactic treatment, rising awareness among people, rising number of auto-immune diseases and beneficial reimbursement policies. Generally, AH is found in old age population and has a mortality rate of 21%, if not treated. Hemophilia A, is the most severe and commonly found type of Acquired Hemophilia. The challenges faced by AH Treatment Market are: high cost of treatment hindering penetration in low and middle income countries, lack of availability and accessibility of new drugs and adoption rate of technologically advanced products is low.

Healthcare Infrastructure in NA Offers Effective Access to Therapeutic Options

On the basis of regional segmentation, Acquired Hemophilia Treatment Market includes North America, Latin America, Europe, Asia Pacific, Middle East and Africa, and Rest of the World. North America dominated the AH Treatment Market in 2020. The key drivers of this market in North America have been U.S. people getting diagnosed at young age, growing awareness among people, better medical health facilities, the favorable reimbursement scenario for medicines prescribed for the treatment of acquired hemophilia further strengthens the region's market development. The European Medical Agency (EMA) created a supportive regulatory climate by authorizing FastTrack classification for drug discovery and production of medicines for treating acquired hemophilia, putting Europe in second place.

Company Profiles

• Baxter Healthcare Corporation
• Biogen
• Sanofi
• Shire (Baxalta)
• CSL Behring
• Pfizer Inc.
• Bayer AG
• Ferring Pharmaceuticals
• Spark Therapeutics Inc.
• F. HOFFMAN LA ROCHE
• Sanofi
• Genentech Inc.
• Novo Nordisk
• GlaxoSmithKline Plc
• Bristol-Myers Squibb

   

Key Topics Covered:

• Preface
• Executive Summary
• Acquired Hemophilia Treatment Market: Market Dynamics and Future Outlook
• Acquired Hemophilia Treatment Market, By Type, 2019 - 2029 (US$ Mn)
• Acquired Hemophilia Treatment Market, By Treatment, 2019 - 2029 (US$ Mn)
• Acquired Hemophilia Treatment Market, By Therapeutic Areas, 2019 - 2029 (US$ Mn)
• Acquired Hemophilia Treatment Market, By Type of End User, 2019 - 2029 (US$ Mn)
• Acquired Hemophilia Treatment, By Regional Market Analysis, 2019 - 2029 (US$ Mn)
• North America Acquired Hemophilia Treatment, Regional Market Analysis, 2019 - 2029 (US$ Mn)
• Latin America Acquired Hemophilia Treatment, Regional Market Analysis, 2019 - 2029 (US$ Mn)
• Europe Acquired Hemophilia Treatment, Regional Market Analysis, 2019 - 2029 (US$ Mn)
• Asia Pacific Acquired Hemophilia Treatment, Regional Market Analysis, 2019 - 2029 (US$ Mn)
• Middle East & Africa (MEA)Acquired Hemophilia Treatment, Regional Market Analysis, 2019 - 2029 (US$ Mn)

For more information about this report visit https://www.researchandmarkets.com/r/rilgu5

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.